Valuation: genOway

Market Cap 23.7M 27.12M 21.87M 20.15M 37.99M 2.61B 38.83M 261M 103M 1.28B 102M 99.6M 4.4B P/E 2024 *
-
P/E 2025 -
Enterprise Value 30.41M 34.8M 28.07M 25.87M 48.76M 3.35B 49.84M 335M 132M 1.64B 131M 128M 5.65B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day-1.53%
1 week+7.08%
Current month+8.44%
1 month+8.44%
3 months+2.80%
6 months+0.78%
Current year-5.17%
1 week 2.28
Extreme 2.28
2.63
1 month 2.21
Extreme 2.21
2.63
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 1999-02-28
Director of Finance/CFO - 2015-09-30
Director TitleAgeSince
Director/Board Member - 1999-02-28
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
1/20/22 Buy

Chief Executive Officer

12,500 0.1376%
11/17/21 Sell

Chief Executive Officer

5,000 0.0553%
11/13/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-1.53%+7.08%-17.36%-35.43% 27.12M
-1.29%-3.11%-0.35%+3.09% 49.18B
+3.90%-0.39%+386.06%+593.85% 39.58B
-1.70%+4.46%+5.93%+60.25% 34.69B
-2.01%-0.76%+28.41%-8.01% 34.42B
+0.06%+0.34%+2.38%+34.38% 27.11B
+0.46%-3.49% - - 16.21B
-0.04%-0.09%+72.42%+115.55% 15.36B
+1.12%+1.91%+14.54%+19.16% 14.05B
0.00%+1.36%+18.43%-30.79% 13.02B
Average -0.10%+0.73%+56.72%+83.56% 24.37B
Weighted average by Cap. -0.05%-0.18%+79.43%+123.30%

Financials

2024 2025
Net sales 27.53M 31.5M 25.41M 23.42M 44.14M 3.03B 45.12M 304M 119M 1.49B 118M 116M 5.12B 28.6M 32.73M 26.39M 24.33M 45.85M 3.15B 46.87M 315M 124M 1.54B 123M 120M 5.31B
Net income 1.83M 2.09M 1.69M 1.56M 2.93M 202M 3M 20.19M 7.94M 98.81M 7.87M 7.69M 340M 928K 1.06M 856K 789K 1.49M 102M 1.52M 10.23M 4.02M 50.07M 3.99M 3.9M 172M
Net Debt 623K 713K 575K 530K 999K 68.65M 1.02M 6.87M 2.7M 33.62M 2.68M 2.62M 116M 6.72M 7.69M 6.2M 5.71M 10.77M 740M 11.01M 74.1M 29.14M 363M 28.87M 28.24M 1.25B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
26-07-17 €2.570 -1.53% 5,141
26-07-16 €2.610 +9.66% 165,788
26-07-15 €2.380 +1.71% 4,094
26-07-14 €2.340 -1.68% 1,572
26-07-13 €2.380 -0.83% 7,552
  1. Stock Market
  2. Stocks
  3. ALGEN Stock